Cleveland Diagnostics company information, Employees & Contact Information

Cleveland at forefront of prostate cancer diagnosis to help saves lives Cleveland 19 News

Cleveland Diagnostics Brings PSA on PSA Campaign Back This September Yahoo Finance

Cleveland Diagnostics Announces Landmark Longitudinal Study Published in Urology Business Wire

Innovative Breakthrough in Cancer Testing Developed in Ohio Fierce Biotech

How Cleveland Diagnostics leveraged $75M in funding for major growth Crain's Cleveland Business

Cleveland Diagnostics secures $75 million funding to advance early-stage cancer detection ohiotechnews.com

Wilson Sonsini Advises Cleveland Diagnostics on $75 Million Growth Capital Financing Wilson Sonsini

Cleveland Diagnostics re-ups prostate-specific antigen test push in 'A PSA on PSA' Fierce Pharma

Cleveland Diagnostics’ PSA on PSA targets the falling screening rates for prostate cancer Medical Marketing and Media

Genomic Health and Cleveland Diagnostics Announce Strategic Collaboration to Develop and Commercialize New Prostate Cancer Tests PR Newswire

Diagnostics companies enter agreement to expand access to blood-based IsoPSA test Urology Times

Dr. Arnon Chait | Power 150 2024 Crain's Cleveland Business

Next-gen prostate cancer test maker Cleveland Diagnostics rocks to $75M fundraising Fierce Biotech

Diagnostics company opens new facility to scale up production of IsoPSA test for prostate cancer Urology Times

Cleveland Diagnostics Announces Agreement with Quest Diagnostics to Expand Patient Access to IsoPSA Business Wire

Cleveland Diagnostics secures over $75 million in funding for early detection cancer tests Crain's Cleveland Business

Cleveland Diagnostics Completes $75M Financing to Advance its Early-detection Oncology Testing Platform Business Wire

Cleveland Diagnostics expands to ramp up cancer test production at Tyler Village The Business Journals

Cleveland Diagnostics has a PSA on PSAs in prostate cancer push Medical Marketing and Media

ClevelandDx reboots 'A PSA on PSA' campaign to drive prostate cancer screening Fierce Pharma

Cleveland Diagnostics expands in the city Crain's Cleveland Business

ICYMI May 2023: The End of the COVID-19 PHE Quest Diagnostics Newsroom

Cleveland Diagnostics: $75 Million Raised For Developing Early Cancer Detection Tests Pulse 2.0

The great prostate debate: innovations in prostate cancer screening Drug Target Review

Mark Stovsky | Notable Leaders in Health Care Technology 2025 Crain's Cleveland Business

FDA Grants Breakthrough Designation to Non-Invasive Prostate Cancer Diagnostic Test Chief Healthcare Executive

Innovations in Prostate Cancer Care Cleveland Clinic

Real-World Study Supports IsoPSA as a Prostate Cancer Biomarker Cleveland Clinic

Quest Diagnostics launches cardiometabolic center at Cleveland HeartLab The Business Journals

Cleveland Clinic-led Study Finds That New Blood Test is More Accurate in Predicting Overall Risk of Prostate Cancer than Standard Prostate-Specific Antigen (PSA) Cleveland Clinic Newsroom

5 Innovations That Are Changing the Delivery of Prostate Cancer Care Cleveland Clinic

Cleveland Diagnostics receives FDA Breakthrough Device Designation for a prostate cancer diagnostic test Crain's Cleveland Business

Quest Diagnostics Releases 2023 Corporate Responsibility Report Quest Diagnostics Newsroom

Clearer Diagnostics, Improved Chances: The Big-Picture Impacts of Improved Cancer Diagnostic Testing Technology Networks

Diagnostics & Testing Cleveland Clinic

Quest Diagnostics Completes Acquisition of Cleveland HeartLab and Formalizes R&D Collaboration with Cleveland Clinic PR Newswire

FDA grants breakthrough status to next-generation PSA test MedTech Dive

How Do I Pay My Bill? Cleveland Clinic

Novartis pumps $7.5M into push to save 100,000 lives from prostate cancer by 2035 Fierce Pharma

IsoPSA Prostate Cancer Test Better Than PSA Test at Detecting Tumors Bionews

FDA Grants Breakthrough Device Designation to IsoPSA Blood Test for PC Diagnosis Bionews

Quest Diagnostics to Acquire Cleveland HeartLab and Form Strategic Collaboration with Cleveland Clinic PR Newswire

Ohio tech startups to benefit from JumpStart funding closure Cleveland.com

New PSA Test Examines Protein Structures To Detect Prostate Cancers Cleveland Clinic Newsroom

Mark Stovsky, MD MBA Cleveland Jewish News

Redmond Waltz electric motor repair company sold to CEO — plus 3 more M&A deals to know The Business Journals

Cleveland Clinic Innovations creates thriving companies out of research Fresh Water Cleveland

Quest Diagnostics to acquire Cleveland Clinic spinoff Cleveland HeartLab Cleveland.com

Electrolytes: Types, Purpose & Normal Levels Cleveland Clinic

A deal with heart Smart Business Dealmakers

HDL Cholesterol Function Lab Test Offers Novel Insight into Cardiovascular Disease Risk, Reports Quest Diagnostics at American Heart Association 2019 Scientific Sessions PR Newswire

$600M+ Credit Firm Targets Life-Sci Companies in Later Stages Genetic Engineering and Biotechnology News

Symbiotic Capital Launches With More Than $600M to Provide Life Science Loans BioSpace